CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2025	Jun. 30, 2024
Cash flows from continuing operating activities:
Loss from continuing operations	$ (10,391)	$ (21,582)
Adjustments to reconcile loss from continuing operations to net cash provided by continuing operating activities:
Stock-based compensation expense	10,020	13,630
Depreciation and amortization	6,335	7,370
Reduction in carrying amount of right-of-use assets	2,224	2,364
Other	(149)	(713)
Changes in operating assets and liabilities:
Accounts receivable, net	(232)	1,346
Other current and non-current assets	96	1,488
Accounts payable	2,754	1,801
Accrued and other current liabilities	(2,942)	(190)
Seller payable	1,203	(2,411)
Operating lease liabilities	(2,331)	(2,850)
Other non-current liabilities	(500)	0
Net cash provided by continuing operating activities	6,087	253
Cash flows from continuing investing activities:
Purchases of marketable securities	(9,089)	(15,153)
Sale and maturities of marketable securities	15,154	13,000
Purchases of property and equipment	(5,094)	(1,974)
Net cash provided by (used in) continuing investing activities	971	(4,127)
Cash flows from continuing financing activities:
Repayment of debt	(2,000)	(2,000)
Proceeds from issuance of stock-based awards	14,852	1,788
Payments of withholding taxes on stock-based awards	(10,769)	(2,450)
Net cash provided by (used in) continuing financing activities	2,083	(2,662)
Net change in cash, cash equivalents and restricted cash from continuing operations	9,141	(6,536)
Net cash flow used in discontinued operating activities	0	(3,831)
Net cash flow used in discontinued investing activities	0	(817)
Net change in cash, cash equivalents and restricted cash from discontinued operations	0	(4,648)
Effect of exchange rate changes on cash, cash equivalents, and restricted cash	0	(160)
Net change in cash, cash equivalents, and restricted cash	9,141	(11,344)
Cash, cash equivalents, and restricted cash, beginning of period	40,488	61,469
Cash, cash equivalents, and restricted cash, end of period	$ 49,629	$ 50,125